Global Report

August 2011
Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p10
The article offers news briefs related to the pharmaceutical industry around the world including the healthcare reform in Germany which limits pharmaceutical company's charges on prescription drugs, the plan of the European Medicines Agency (EMA) to provide public access on information of drugs side effects and the increased spending of Great Britain's National Cancer Research Institute on cancer research.


Related Articles

  • Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation. Ruof, Jörg; Schwartz, Friedrich; Schulenburg, J.-Matthias; Dintsios, Charalabos-Markos // European Journal of Health Economics;Jul2014, Vol. 15 Issue 6, p577 

    Objectives: Since the introduction of the German health care reform in January 2011, an early benefit assessment (EBA) is required for all new medicines. Pharmaceutical manufacturers have to submit a benefit dossier for evaluation by the Institute for Quality and Efficiency in Health Care...

  • E-Zigaretten dürfen frei verkauft werden.  // Lebensmittel Zeitung;9/20/2013, Issue 38, p28 

    The article presents information on a German court decision which deals with the claim to certify electronic cigarettes as medication.

  • Experts criticise proposed new German law for favouring drug companies. Tuffs, Annette // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/16/2010, Vol. 341 Issue 7777, p798 

    The article deals with the warning issued by experts on the safety implications of a proposed law on approving drugs for reimbursement by German insurance companies.

  • Impact of drug discount contracts on pharmacies and on patients' drug supply. Gröber-Grätz, Dagmar; Gulich, Markus // Journal of Public Health (09431853);Dec2010, Vol. 18 Issue 6, p583 

    Introduction: Since April 2007, health insurance companies in Germany have been entitled to negotiate drug discount contracts (DDCs) with pharmaceutical manufacturers for particular drugs. DDCs commit pharmacists to dispense the drug made by this manufacturer. The aim of this study was to...

  • New law in Germany working.  // PharmacoEconomics & Outcomes News;3/17/2012, Issue 649, p3 

    The article reports on the implementation of a law that fixes drug prices in Germany.

  • New German drug law: towards value-based pricing?  // PharmacoEconomics & Outcomes News;7/9/2011, Issue 632, p3 

    This article discusses the introduction of a drug pricing law by the German government in January 2011.

  • Warenkunde.  // Lebensmittel Zeitung;12/20/2013, Issue 51, p1 

    The article offers information on a seminar discussing medication, which can be bought in retail stores, and its legislation to be held in Neuwied, Germany in January and April 2014.

  • The best of BioWorld on Twitter.  // BioWorld Today;1/21/2014, Vol. 25 Issue 13, p9 

    A list of the stories on the biopharmaceutical industry which have been posted on the social media Twitter is presented, including competition among biotech firms, allocation of funds for cancer research and availability of funding options for the industry.

  • EU Member States. Hagenmeyer, Moritz // European Food & Feed Law Review;2011, Vol. 6 Issue 1, p51 

    The article discusses the law implemented in Germany that considers foodstuffs containing other substances than vitamins and minerals that are subject to authorization under the German Food and Feed Act (LFGB). The author presents a case wherein a food supplement containing glucosamine and...

  • Intoxicating trends. Harris, Victoria // History Today;Apr2012, Vol. 62 Issue 4, p3 

    The article discusses attitudes toward drug use since the nineteenth century, examining scientific, ideological, and economic factors. It comments on the introduction of aspirin and heroin into the drug market by pharmaceutical company Bayer in 1897. The author addresses fashion's impact on drug...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics